Clinical Trials Logo

Filter by:
NCT ID: NCT04808050 Completed - Clinical trials for Non-small Cell Lung Cancer

Real-world Treatment Patterns and Associated Outcomes in Patients With Resectable Early-stage Non-small Cell Lung Cancer

THASSOS-INTL
Start date: November 3, 2021
Phase:
Study type: Observational

This is a non-interventional, multi-country, multicentre, retrospective study designed to determine the treatment patterns and associated survival rate in patients with primary stage IA to IIIB resectable NSCLC diagnosed between 01 January 2013 and 31 December 2017 and followed until at least 31 December 2020 The main objective of this study is to describe the treatment patterns and determine their associated 3-year survival rate according to clinical and pathologic staging in patients with resectable early-stage (IA to IIIB as per AJCC seventh edition) NSCLC.

NCT ID: NCT04801186 Completed - Clinical trials for Metastatic Castration-resistant Prostates Cancer

Retrospective Study to Describe the Real-world Treatment Patterns and Associated Clinical Outcomes in Patients With Metastatic Castration-resistant Prostates Cancer

REMPRO
Start date: September 28, 2021
Phase:
Study type: Observational

This is a multi-country, multi-centre, retrospective, non-interventional cohort study planned to include patients diagnosed with mCRPC between 01 January 2016 and 31 December 2018, who have received at least 1 line of treatment (LOT) in the mCRPC setting, and have 12 months of follow-up data available.

NCT ID: NCT04760730 Completed - COVID-19 Clinical Trials

Safety and Immunogenicity Study in Adults of AZD1222 and rAd26-S Administered as Heterologous Prime Boost Regimen for the Prevention of Coronavirus Disease 2019 (COVID-19)

Start date: July 13, 2021
Phase: Phase 1/Phase 2
Study type: Interventional

This is a Phase I/II, parallel group, single blinded (participant blinded), randomised study assessing the immunogenicity and safety of AZD1222 and rAd26-S administered as heterologous prime-boost in alternating order in 2 study groups for the Prevention of COVID-19.

NCT ID: NCT04690959 Completed - Clinical trials for Physical and Rehabilitation Medicine

Comparative Effects of Tensioning and Sliding Neural Mobilization on Nerve Root Function

Start date: January 1, 2021
Phase: N/A
Study type: Interventional

the current study will try to answer the question: Is it theoretically possible, that increased longitudinal stress on nerve root from sliding or tensioning intervention may subtly affect the neural function? Our hypothesis is that tensioning and sliding, differently affect the neural function.

NCT ID: NCT04665960 Completed - Covid19 Clinical Trials

Infection Control for Severe Acute Respiratory Syndrome Coronavirus 2

IC-COVID-19
Start date: March 29, 2021
Phase:
Study type: Observational

The investigators aim to develop expert consensus statements on infection control management of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in intensive care units (ICU).

NCT ID: NCT04645485 Completed - Healthy Clinical Trials

Safety and Tolerability of Autologous Non-hematopoietic Peripheral Blood Stem Cells Therapy in Healthy Adult Volunteers.

SANTANA
Start date: May 12, 2020
Phase: Phase 1
Study type: Interventional

SANTANA Study is a phase 1, prospective, monocentric, open-label clinical trial involving healthy adult volunteers, with the objective to evaluate the safety and tolerability of the compressor nebulization of autologous non-hematopoietic peripheral blood stem cells (NHPBSC).

NCT ID: NCT04610060 Completed - Clinical trials for Coronary Artery Disease

Power Walking in Cardiac Patients Who Underwent Post-coronary Angioplasty

PowerWalk
Start date: April 7, 2020
Phase: N/A
Study type: Interventional

The risk and prevalence of cardiovascular disease in United Arab Emirates (UAE) is high with ischemic heart disease ranks first in terms of major cause of mortality. Large number of patients undergoes coronary angioplasty but very few participate in cardiac rehabilitation because its awareness is not widespread in middle east region. The objectives was to find the influence of standardized outpatient cardiac rehabilitation program along with power walking on Heart quality of life (Heart QoL), functional exercise capacity, Left Ventricular Ejection Fraction and metabolic equivalent task (MET's) among patients with post coronary angioplasty. The investigators conducted a randomized clinical trail in out patient physiotherapy department at Thumbay hospitals Dubai, on patients who underwent coronary artery angioplasty. After meeting the inclusion criteria, participants were randomized into standardized outpatient cardiac rehabilitation program along with power walking (intervention group) or standardized outpatient cardiac rehabilitation program (control group). A 4 weeks of 12 outpatient cardiac rehabilitation sessions consisting of 3 sessions per week was provided to both the groups. Intervention group received standardized outpatient cardiac rehabilitation program along with power walking based on targeted heart rate and weekly steps, whereas control group received only standardized outpatient cardiac rehabilitation program based on American College of Sports Medicine (ACSM) Guidelines. The investigators measured Quality Of Life (HRQoL) by HeartQoL questionnaire, Exercise Capacity by 6 min walk test (6MWT), Left ventricle Ejection fraction (LVEF) using Echocardiogram, Metabolic Equivalent Task (MET'S) using Symptom-limited exercise stress test and Average number of steps walked daily using step up smartphone Pedometer App.

NCT ID: NCT04602351 Completed - COVID-19 Clinical Trials

Communication in ICU During COVID-19

Start date: March 22, 2021
Phase:
Study type: Observational

This study explores the actual situation of communication during the Coronavirus disease 2019 (COVID-19) pandemic in the South Asia and Middle East region. The purpose is to assess the effect of the limited visitor policy during the COVID-19 pandemic, on the pattern of interaction of critically ill patients to their kin/ guardian and doctor-family members communication. Primary objective of this study are as follows: 1. Explore the changes in communication pattern with limited contact during the COVID-19 pandemic. 2. Assess the methods of informed consent in Intensive care units (ICUs) during the same period

NCT ID: NCT04538716 Completed - Eyelid Diseases Clinical Trials

Retroseptal Transconjunctival Blepharoplasty for GIR

Start date: August 1, 2019
Phase: N/A
Study type: Interventional

The tear trough deformity is a challenging cosmetic condition.surgical treatment and filling are good treatment options

NCT ID: NCT04534569 Completed - Covid19 Clinical Trials

Expert Panel Statement for the Respiratory Management of COVID-19 Related Acute Respiratory Failure (C-ARF)

Start date: September 4, 2020
Phase:
Study type: Observational

The investigators aim to achieve experts consensus on respiratory interventions in management of COVID-19 related acute respiratory failure (C-ARF).